203 related articles for article (PubMed ID: 17617046)
1. Innate alloimmunity: history and current knowledge.
Land W
Exp Clin Transplant; 2007 Jun; 5(1):575-84. PubMed ID: 17617046
[TBL] [Abstract][Full Text] [Related]
2. Activation of the innate immune system by the endogenous ligand hyaluronan.
Shirali AC; Goldstein DR
Curr Opin Organ Transplant; 2008 Feb; 13(1):20-5. PubMed ID: 18660702
[TBL] [Abstract][Full Text] [Related]
3. Emerging science, emerging ethical issues: who should fund innate alloimmunity-suppressing drugs?
Land WG; Gutmann T; Daar AS
Acta Chir Belg; 2008; 108(1):73-82. PubMed ID: 18411578
[TBL] [Abstract][Full Text] [Related]
4. Innate immunity-mediated allograft rejection and strategies to prevent it.
Land WG
Transplant Proc; 2007 Apr; 39(3):667-72. PubMed ID: 17445569
[TBL] [Abstract][Full Text] [Related]
5. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
Goldstein DR; Palmer SM
J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors and other links between innate and acquired alloimmunity.
Goldstein DR
Curr Opin Immunol; 2004 Oct; 16(5):538-44. PubMed ID: 15341996
[TBL] [Abstract][Full Text] [Related]
7. Toll like receptors and acute allograft rejection.
Goldstein DR
Transpl Immunol; 2006 Dec; 17(1):11-5. PubMed ID: 17157206
[TBL] [Abstract][Full Text] [Related]
8. Roles of toll-like receptors signaling in organ transplantation.
Li T; Chen G; Zhang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1125-33. PubMed ID: 22246357
[TBL] [Abstract][Full Text] [Related]
9. Tracking the toll of kidney disease.
Shirali AC; Goldstein DR
J Am Soc Nephrol; 2008 Aug; 19(8):1444-50. PubMed ID: 18579638
[TBL] [Abstract][Full Text] [Related]
10. Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation.
Palmer SM; Burch LH; Mir S; Smith SR; Kuo PC; Herczyk WF; Reinsmoen NL; Schwartz DA
Clin Transplant; 2006; 20(1):30-6. PubMed ID: 16556150
[TBL] [Abstract][Full Text] [Related]
11. Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model.
Hummel M; Kurian SM; Lin S; Borodyanskiy A; Zhang Z; Li Z; Kim SJ; Salomon DR; Abecassis M
Transplantation; 2009 Jan; 87(2):178-88. PubMed ID: 19155971
[TBL] [Abstract][Full Text] [Related]
12. Cardiac allograft rejection correlates with increased expressions of Toll-like receptors 2 and 4 and allograft inflammatory factor 1.
McDaniel DO; Zhou X; Moore CK; Aru G
Transplant Proc; 2010 Dec; 42(10):4235-7. PubMed ID: 21168672
[TBL] [Abstract][Full Text] [Related]
13. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation.
Land WG
Transplantation; 2005 Mar; 79(5):505-14. PubMed ID: 15753838
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury.
Wang Y; Abarbanell AM; Herrmann JL; Weil BR; Poynter J; Manukyan MC; Crisostomo PR; Meldrum DR
Shock; 2010 Dec; 34(6):548-57. PubMed ID: 20458266
[TBL] [Abstract][Full Text] [Related]
15. Impact of innate and adaptive immunity on rejection and tolerance.
Kim IK; Bedi DS; Denecke C; Ge X; Tullius SG
Transplantation; 2008 Oct; 86(7):889-94. PubMed ID: 18852649
[TBL] [Abstract][Full Text] [Related]
16. Injury to allografts: innate immune pathways to acute and chronic rejection.
Land WG
Saudi J Kidney Dis Transpl; 2005; 16(4):520-39. PubMed ID: 18202507
[TBL] [Abstract][Full Text] [Related]
17. The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts.
Noris M; Cassis P; Azzollini N; Cavinato R; Cugini D; Casiraghi F; Aiello S; Solini S; Cassis L; Mister M; Todeschini M; Abbate M; Benigni A; Trionfini P; Tomasoni S; Mele C; Garlanda C; Polentarutti N; Mantovani A; Remuzzi G
J Immunol; 2009 Oct; 183(7):4249-60. PubMed ID: 19734209
[TBL] [Abstract][Full Text] [Related]
18. Cold ischaemia, innate immunity and deterioration of the glomerular filtration barrier in antibody-mediated acute rejection.
Ripoll È; Nacher V; Vidal A; Herrero E; Bolaños N; Torras J; Grinyó JM; Ruberte J; Herrero-Fresneda I
Nephrol Dial Transplant; 2012 Aug; 27(8):3296-305. PubMed ID: 22555253
[TBL] [Abstract][Full Text] [Related]
19. Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients.
Braudeau C; Ashton-Chess J; Giral M; Dugast E; Louis S; Pallier A; Braud C; Moreau A; Renaudin K; Soulillou JP; Brouard S
Transplantation; 2008 Jul; 86(1):130-6. PubMed ID: 18622290
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of innate immunity in organ transplantation: part I: evolution of innate immunity and oxidative allograft injury.
Land WG
Transplant Rev (Orlando); 2012 Apr; 26(2):60-72. PubMed ID: 22000662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
